V. Minotti

759 total citations
22 papers, 385 citations indexed

About

V. Minotti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, V. Minotti has authored 22 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in V. Minotti's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (6 papers) and Neutropenia and Cancer Infections (4 papers). V. Minotti is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (6 papers) and Neutropenia and Cancer Infections (4 papers). V. Minotti collaborates with scholars based in Italy, United States and Taiwan. V. Minotti's co-authors include Maurizio Tonato, A. Del Favero, Lucio Crinò, E. Corgna, Giampaolo Bucaneve, C. Basurto, Fausto Roila, Enzo Ballatori, Michael A. Palladino and Rita Chiari and has published in prestigious journals such as Pain, Annals of Oncology and European Journal of Cancer.

In The Last Decade

V. Minotti

22 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Minotti Italy 12 200 189 85 45 39 22 385
Arnaud Deroover Belgium 15 127 0.6× 221 1.2× 531 6.2× 36 0.8× 11 0.3× 34 695
Elaine M. Sillos United States 7 69 0.3× 129 0.7× 47 0.6× 42 0.9× 51 1.3× 8 349
Zeki Aydın Türkiye 9 61 0.3× 73 0.4× 46 0.5× 37 0.8× 14 0.4× 38 276
Aage Knudsen Denmark 14 37 0.2× 82 0.4× 102 1.2× 93 2.1× 11 0.3× 25 467
Hiromi Nihira Japan 11 52 0.3× 118 0.6× 102 1.2× 60 1.3× 5 0.1× 42 330
Abdullah Çetin Türkiye 12 58 0.3× 59 0.3× 181 2.1× 72 1.6× 8 0.2× 29 423
Woo‐Baek Chung South Korea 11 73 0.4× 98 0.5× 45 0.5× 40 0.9× 7 0.2× 52 385
Jesús Montoliu Spain 10 99 0.5× 134 0.7× 39 0.5× 229 5.1× 3 0.1× 13 499
A Loganayagam United Kingdom 8 169 0.8× 48 0.3× 43 0.5× 61 1.4× 4 0.1× 15 288
Fumiaki Kiyomi Japan 11 104 0.5× 181 1.0× 58 0.7× 29 0.6× 8 0.2× 36 365

Countries citing papers authored by V. Minotti

Since Specialization
Citations

This map shows the geographic impact of V. Minotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Minotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Minotti more than expected).

Fields of papers citing papers by V. Minotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Minotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Minotti. The network helps show where V. Minotti may publish in the future.

Co-authorship network of co-authors of V. Minotti

This figure shows the co-authorship network connecting the top 25 collaborators of V. Minotti. A scholar is included among the top collaborators of V. Minotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Minotti. V. Minotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Felip, Enriqueta, V. Minotti, Julius Wolf, et al.. (2021). P76.03 Efficacy and Safety of Capmatinib Plus Nivolumab in Pretreated Patients with EGFR Wild-Type Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(3). S585–S586. 4 indexed citations
2.
Felip, Enriqueta, V. Minotti, Ross A. Soo, et al.. (2020). 1284P MET inhibitor capmatinib plus EGFR tyrosine kinase inhibitor nazartinib for EGFR-mutant non-small cell lung cancer. Annals of Oncology. 31. S829–S830. 8 indexed citations
3.
Ricciuti, Biagio, Giulio Metro, Piero Ferollà, et al.. (2015). Clinical outcome of platinum/etoposide treated large cell neuroendocrine carcinomas of the lung according to the type of radiotherapy received: a single institution analysis. Annals of Oncology. 26. vi78–vi78. 2 indexed citations
4.
Ludovini, Vienna, Antonella Flacco, Fortunato Bianconi, et al.. (2013). Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients. Cancer Chemotherapy and Pharmacology. 71(3). 671–680. 14 indexed citations
5.
Ludovini, Vienna, Fortunato Bianconi, Lorenza Pistola, et al.. (2012). Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. Cancer Chemotherapy and Pharmacology. 69(5). 1289–1299. 35 indexed citations
6.
7.
Metro, Giulio, Rita Chiari, Diana Giannarelli, et al.. (2011). Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation. Cancer Chemotherapy and Pharmacology. 68(6). 1405–1412. 16 indexed citations
8.
Gregorc, Vanesa, Vienna Ludovini, Lorenza Pistola, et al.. (2001). p53 overexpression predicts the resistance to chemotherapy in advanced non small cell lung cancer (NSCLC). European Journal of Cancer. 37. S118–S118. 1 indexed citations
9.
Minotti, V., Giuseppe Gentile, Giampaolo Bucaneve, et al.. (1999). Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment. Supportive Care in Cancer. 7(3). 134–139. 31 indexed citations
10.
Minotti, V., et al.. (1998). Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer. Lung Cancer. 20(2). 93–98. 71 indexed citations
11.
Minotti, V., Enrico Righetti, Maria Grazia Celani, et al.. (1998). Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain. Pain. 74(2). 133–137. 35 indexed citations
12.
13.
14.
Darwish, Samir, V. Minotti, Lucio Crinò, et al.. (1994). Neoadjuvant Cisplatin and Etoposide for Stage IIIA (Clinical N2) Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 17(1). 64–67. 16 indexed citations
15.
Fontanini, Gabriella, et al.. (1994). The impact of angiogenesis on the metastasis in resected patients with stage IIIA N2 non small cell lung cancer (NSCLC). Lung Cancer. 11. 47–47. 2 indexed citations
16.
Crinò, Lucio, Paolo Latini, E. Corgna, et al.. (1993). Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer. Annals of Oncology. 4(10). 846–850. 30 indexed citations
17.
Favero, A. Del, Fausto Roila, C. Basurto, et al.. (1990). Assessment of nausea. European Journal of Clinical Pharmacology. 38(2). 115–120. 43 indexed citations
18.
Bucaneve, Giampaolo, et al.. (1989). Ceftriaxone versus Imipenem/Cilastatin as Empirical Monotherapy for Infections in Cancer Patients. Chemotherapy. 35(2). 10–15. 12 indexed citations
19.
20.
Favero, A. Del, F. Menichetti, Giampaolo Bucaneve, V. Minotti, & S Pauluzzi. (1988). Septicaemia due to Gram-positive cocci in cancer patients. Journal of Antimicrobial Chemotherapy. 21(suppl C). 157–162. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnaud Deroover Breakdown of academic impact, for papers by Elaine M. Sillos Breakdown of academic impact, for papers by Zeki Aydın Breakdown of academic impact, for papers by Aage Knudsen Breakdown of academic impact, for papers by Hiromi Nihira Breakdown of academic impact, for papers by Abdullah Çetin Breakdown of academic impact, for papers by Woo‐Baek Chung Breakdown of academic impact, for papers by Jesús Montoliu Breakdown of academic impact, for papers by A Loganayagam Breakdown of academic impact, for papers by Fumiaki Kiyomi
Rankless by CCL
2026